| 000 | 00884nam a22002657i 4500 | ||
|---|---|---|---|
| 005 | 20170307111038.0 | ||
| 008 | 980424s1998 sp gr 000 0 spa c | ||
| 040 |
_aSIIS _bspa |
||
| 041 | _aeng | ||
| 100 | 1 |
_aCOULTER, D.L. _9239923 |
|
| 245 | 1 | 0 | _aEFFECTIVENESS AND COST OF GENERIC VERSUS BRAND-NAME VALPROIC ACID |
| 650 | 1 | 4 |
_aCrítica _9239924 |
| 650 | 1 | 4 |
_aDiscapacidad _9239925 |
| 650 | 1 | 4 |
_aDiscapacidad intelectual _9484 |
| 650 | 1 | 4 |
_aEpilepsia _92670 |
| 650 | 1 | 4 |
_aFármacos _9921 |
| 653 | 1 | 0 | _aDiscapacidad |
| 655 | 4 |
_aDocumental _9239926 |
|
| 773 | 0 |
_tMENTAL RETARDATION _gVol. 35, no. 6 (1997), p. 472-475 |
|
| 856 | 4 | 0 |
_zPath _u\\Srvdatos\siis\docus\Revistas electrónicas\Intellectual and Developmental Disabilities R.101\1997\Effectiveness and Cost of Generic Versus Brand-Name Valproic Acid.pdf |
| 996 | 1 | 0 | _a11.1 |
| 996 | 1 | 0 | _a45 |
| 997 | _a65944 | ||
| 998 | _aAR | ||
| 939 | _a19980424 | ||
| 999 |
_c65295 _d65295 |
||